Date | EBT Margin | Net Income Margin | EBITDA Margin | EBIT Margin |
---|
CEO | Mr. Junzheng Zhang |
IPO Date | Aug. 25, 2010 |
Location | China |
Headquarters | 1708-1710 Huijin Center |
Employees | 1,165 |
Sector | Health Care |
Industries |
Boai NKY Medical Holdings Ltd. develops, manufactures, and sells polyvinylpyrrolidone (PVP) series products worldwide. The company offers KoVidone and PolyKoVidone line of products representing Povidone, Crospovidone, and Copovidone pharmaceutical excipients; OraRez line of PVM/MA copolymer and derivatives representing functional polymers for bioadhesive/mucoadhesive applications; KoVidone-1 broad spectrum biocidal, antifungal, and antiviral agents; and pharmaceutical solvents and intermediates. It also offers polymers, vinyl and vinyl ether compounds, PolyViscol, KoVidone I, WhiVidone, and PVPP. Its products are used in pharma, industrial, oral care, cosmetics, food and beverage, and other sectors. The company was formerly known as Boai NKY Pharmaceuticals Ltd. and changed its name to NKY medical holding Ltd. in March 2016. Boai NKY Medical Holdings Ltd. was founded in 1987 and is based in Heping, China.
Past 5 years
USD 4.41
USD 1.63
USD 2.41
USD 0.84
USD 2.00
StockViz Staff
January 16, 2025
Any question? Send us an email